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ABSTRACT
Injection of the Helicobacter pylori cytotoxin-associated gene A (CagA) is closely 
associated with the development of chronic gastritis and gastric cancer. Individuals 
infected with H. pylori possessing the CagA protein produce more reactive oxygen 
species (ROS) and show an increased risk of developing gastric cancer. Sirtuins 
(SIRTs) are nicotinamide adenine dinucleotide (NAD+)-dependent deacetylases and 
mitochondrial SIRT3 is known to be a tumor suppressor via its ability to suppress 
ROS and hypoxia inducible factor 1α (HIF-1α). However, it is unclear whether 
increased ROS production by H. pylori is regulated by SIRT3 followed by HIF-1α 
regulation and whether intracellular CagA acts as a regulator thereof. In this study, 
we investigated correlations among SIRT3, ROS, and HIF-1α in H. pylori-infected 
gastric epithelial cells. We observed that SIRT3-deficient AGS cells induce HIF-1α 
protein stabilization and augmented transcriptional activity under hypoxic conditions. 
In CagA+ H. pylori infected cells, CagA protein localized to mitochondria where it 
subsequently suppressed SIRT3 proteins. CagA+ H. pylori infection also increased 
HIF-1α activity through the ROS production induced by the downregulated SIRT3 
activity, which is similar to the hypoxic condition in gastric epithelial cells. In contrast, 
overexpression of SIRT3 inhibited the HIF-1α protein stabilization and attenuated 
the increase in HIF-1α transcriptional activity under hypoxic conditions. Moreover, 
CagA+ H. pylori attenuated HIF-1α stability and decreased transcriptional activity in 
SIRT3-overexpressing gastric epithelial cells. Taken together, these findings provide 
valuable insights into the potential role of SIRT3 in CagA+ H. pylori-mediated gastric 
carcinogenesis and a possible target for cancer prevention via inhibition of HIF-1α.
INTRODUCTION
Previous studies have demonstrated that hypoxia 
is an important microenvironmental factor in promoting 
tumor progression [1]. Gastric cancers are exposed to 
hypoxia, as are many other solid tumors. Epidemiological 
studies have suggested that the development of gastric 
cancer may be attributed to hypoxia-induced reactive 
oxygen species (ROS) [2] and that ROS generated within 
the gastric mucosa are related to continuous exposure to 
H. pylori infection, ingested food, and cigarette smoking, 
etc. Accumulating data indicate that the H. pylori CagA 
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protein, which is injected into gastric epithelial cells 
through T4SS, behaves as a bacterial oncoprotein [3]: 
CagA continuously dysregulates multiple oncogenic 
signaling pathways and promotes tumorigenesis [4]. 
Suzuki et al. found that ROS production in gastric 
epithelial cells was significantly enhanced by infection 
with CagA-positive H. pylori strains, resulting in an 
extensive accumulation of neutrophils [5], and was 
involved in tumor initiation, enhanced expression of 
oncogenes, and increased cell proliferation.
Increased ROS production may be involved in 
a variety of cellular changes, including changes in 
metabolism. Alterations in metabolism can help cancer 
cells survive various stresses, such as hypoxia and a 
limited supply of glucose. Some of the metabolic changes 
are facilitated by the transcription factor hypoxia inducible 
factor 1α (HIF-1α) [6]. HIF-1α activation is dependent on 
oxygen levels. Under normoxia, HIF-1α is hydroxylated 
on proline residues by prolyl hydroxylase domain proteins 
(PHDs) and degraded by proteasomes. Under hypoxia, 
HIF-1α is stabilized and translocated into the nucleus 
where it binds to the hypoxia-response element (HRE) 
in the promoters of target genes [1, 7]. Mitochondrial 
electron transport chain-generated ROS can also stabilize 
HIF-1α, resulting in the transcription of genes involved 
in glucose transport and glycolytic enzymes, as well as 
promoting cell proliferation [8, 9].
Several members of the sirtuin family (SIRT1-7), the 
human homologues of the Sir2 gene in yeast, have been 
reported to play important roles in carcinogenesis [10]. 
Sirtuins are a family of nicotinamide adenine dinucleotide 
(NAD+)-dependent protein deacetylases [11]. Sirtuins 
regulate multiple cellular processes and physiological 
states, including oxidative stress, genomic stability, cell 
survival, development, metabolism, aging, and longevity 
[12, 13]. Of the seven SIRT analogues, SIRT3, SIRT4, and 
SIRT5 are localized in the mitochondria [14]. Strikingly, 
SIRT3 deacetylates and activates several enzymes 
involved in cellular redox balance and defense against 
oxidative damage [15–18]. In addition, SIRT3 knock-out 
(KO) murine embryonic fibroblasts (MEFs) have been 
found to cause a shift towards glycolytic metabolism, 
exhibiting faster glucose uptake, lower levels of TCA 
intermediates, higher levels of lactate, and significantly 
faster proliferation, compared to wild-type MEFs [19, 20]. 
Recently, SIRT3 was reported to act as a mitochondrial 
localized tumor suppressor via its ability to inhibit 
mitochondrial ROS production. Loss of SIRT3 has been 
found to increase the production of ROS and to lead to 
HIF-1α stabilization under hypoxic conditions. In contrast, 
SIRT3 overexpression has been shown to impede HIF-1α 
stabilization in hypoxia and to inhibit tumorigenesis [19, 
21, 22]. To our knowledge, the role of SIRT3 in H. pylori-
induced gastric carcinogenesis has not been investigated. 
In this study, we sought to investigate whether SIRT3 
plays a role in the ROS production induced by the H. 
pylori oncoprotein CagA and whether increased ROS can 
affect HIF-1α activation leading to H. pylori-mediated 
gastric carcinogenesis.
Herein, we show that loss of SIRT3 in gastric 
epithelial cells increases HIF-1α protein stabilization and 
its transcriptional activity. Infection with H. pylori CagA 
induced downregulation of SIRT3 protein in mitochondria, 
stimulated ROS production, and elicited HIF-1α 
stabilization with increased transcriptional activity, similar 
to that observed during hypoxia. Meanwhile, however, 
SIRT3-overexpressing gastric epithelial cells inhibited the 
stabilization of HIF-1α protein in hypoxia and attenuated 
the observed increases in HIF-1α transcriptional activity 
in hypoxia. Moreover, H. pylori CagA attenuated HIF-
1α stability and its transcriptional activity in SIRT3-
overexpressing gastric epithelial cells. These findings 
suggest that H. pylori CagA induces HIF-1α activity 
by downregulating SIRT3, followed by increases in 
ROS production, which provides a novel mechanism to 
explain the pathogenesis of H. pylori-mediated gastric 
carcinogenesis.
RESULTS
SIRT3 knockdown increases proliferation of 
gastric epithelial cells and HIF-1α activity 
through ROS generation
Loss of SIRT3 has been shown to increase 
mitochondrial ROS production and HIF-1α activity 
under hypoxic conditions [22]. We sought to investigate 
whether SIRT3 knockdown plays a role in the progression 
of gastric cancer using established gastric epithelial cell 
lines. We knocked down SIRT3 in the gastric epithelial 
cells with short-hairpin (sh)RNA and explored whether 
SIRT3 knockdown affected the hypoxic activation of 
HIF-1α. We found that SIRT3 knockdown in gastric 
epithelial cells under hypoxic conditions resulted in 
increased expression of HIF-1α protein, compared to 
the scrambled control (Figure 1A). We next examined 
whether there is a concomitant increase in HIF-1α 
transcriptional activity using the reporter construct 
with hypoxia responsive element (HRE) [22]. Under 
hypoxic conditions, there was a 40-fold increase in HRE-
luciferase activity in the scrambled control, compared 
with normoxic conditions, whereas the SIRT3 knockdown 
cells demonstrated a 70-fold increase in luciferase activity 
under the same conditions (Figure 1B). Consistent with 
this, the expression of HIF-1α target genes, such as 
Vegf-a, Pdk1, and Ldha, were significantly elevated, 
compared to the control, during hypoxia, and the loss 
of SIRT3 further increased expression of these HIF-1α 
target genes (Figure 1C). Hypoxic conditions have been 
reported to increase ROS production, and these higher 
ROS levels are sufficient to stabilize and activate HIF-
1α [22, 23]. As expected, we also observed increased 
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ROS levels in SIRT3 knockdown AGS cells, compared 
with the control, in hypoxic conditions (Figure 1D). 
To determine whether the source of the increased ROS 
production in the absence of SIRT3 was complex I or III of 
mitochondria, we measured HIF-1α activity by luciferase 
assay in the presence or absence of selective inhibitors of 
mitochondrial complex I or complex III. DPI has been 
used to inhibit ROS production mediated by plasma 
membrane NAD(P)H oxidase [24, 25] and has also been 
reported to inhibit the production of superoxide and H2O2 
by mitochondria through inhibiting NADH-ubiquinone 
oxidoreductase (complex I) [26, 27]. Myxothiazol binds 
at the quinol oxidation (Qo) site of the bc1 complex 
(complex III) to block electron transfer, and impairs ROS 
production [28]. We found that addition of inhibitors 
attenuated the increase in HRE-luciferase activity in the 
SIRT3 knockdown cells cultured under hypoxic conditions 
(Figure 1E), thereby demonstrating that the increase in 
HIF-1α activity with hypoxic conditions is due to ROS 
generated by the mitochondrial electron transport chain. 
To demonstrate the role of SIRT3 in the progression of 
tumors, we injected control and SIRT3 knockdown AGS 
cells into the flanks of nude mice, and tumor growth was 
measured after the subcutaneous injection. We found 
that tumor volume derived from SIRT3 knockdown cells 
was significantly increased, compared with control cells 
Figure 1: SIRT3 knockdown in gastric epithelial cells increases HIF-1α activity and induces tumor growth. (A) SIRT3 
and HIF-1α protein levels were detected by immunoblotting extracts from AGS and MKN28 cells stably expressing a scrambled control 
shRNA (scr) or SIRT3 shRNA at normoxic (N, 21% O2) or hypoxic (H, 1% O2) conditions for 12 h. (B) SIRT3 stable knockdown cell lines 
(shRNA) or a scrambled control vector (scr) line were transfected with HRE-luciferase for 24 h and incubated in normoxic or hypoxic 
conditions for 16 h, after which luciferase reporter activity was measured. (C) RNA was isolated from AGS cells stably expressing SIRT3 
shRNA or a scrambled control vector (scr) cultured in normoxic or hypoxic conditions for 16 h. The expression of HIF-1α target genes in 
response to hypoxia was measured by real-time PCR using specific primers for Vegf-a, Pdk-1, and Ldha. (D) ROS levels were measured 
by FACS analysis for AGS cells with SIRT3 knockdown or a scrambled control (scr) cultured in normoxic or hypoxic conditions for 12 h. 
(E) Scrambled or SIRT3 shRNA stable cell lines were transfected with HRE-luciferase for 24 h, treated with inhibitors DPI or myxothiazol 
for 1 h, and then, incubated in normoxic or hypoxic conditions for 16 h. Firefly luciferase reporter activity was measured and normalized 
to Renilla luciferase activity. (F) AGS cells expressing control or SIRT3 shRNA were subcutaneously injected into the flanks of nude mice 
(n=5). Xenograft tumor volumes were monitored weekly and growth curves were plotted (left panel). Xenograft tumors were excised and 
weighed at the end of the experiment (middle panel). Pictures of dissected tumors are shown in the right panel. Each bar indicates the mean 
± S.E. (n=5; *p<0.05; **p<0.01; *** p < 0.001). (G) Tumor samples from nude mice injected with control, and SIRT3 shRNA AGS cells 
were lysed and immunoblotted with anti-HIF-1α and SIRT3. (H) Vegf-a and Pdk1 expression levels were measured by real-time PCR with 
isolated total RNA from tumor samples. (I) Tumor samples were collected, and immunohistochemical staining was performed with anti-
CD31 antibody. Data are represented as mean ± SD (n = 3). *p<0.05; **p<0.01; *** p < 0.001.
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(Figure 1F). In addition, HIF-1α protein levels and the 
expression of HIF-1α target genes were analyzed, and 
the expression of Vefg-a and Pdk1 were significantly 
increased in SIRT3-deficient tumor tissues, compared with 
the controls, as was the degree of angiogenic activity, as 
determined by immunostaining for the endothelial cell-
specific marker CD31 (Figure 1G-1I). Taken together, 
these results indicate that SIRT3 loss is linked to 
tumorigenesis mediated via ROS-induced HIF-1α activity, 
leading to enhanced angiogenesis and glycolytic pathway 
metabolism.
Infection with H. pylori CagA increases HIF-1α 
activity and expression of HIF-1α target genes
To examine HIF-1α protein expression in relation to 
the oncoprotein CagA secreted by H. pylori, extracts from 
cells infected with H. pylori strains were immunoblotted 
using HIF-1α antibody. In this experiment, we used four 
strains of H. pylori (two CagA-negative and two CagA-
positive strains) and confirmed the expression of CagA 
protein in CagA+ strains (60190 and ΔvacA 60190) 
(Figure 2A). Surprisingly, stronger expression of HIF-1α 
protein was observed in CagA+ H. pylori strains than in 
the CagA- strains (Figure 2B, Supplementary Figure 1). 
Immunoblotting of cytosolic and nuclear fractions showed 
that infection with CagA+ H. pylori induced greater HIF-
1α nuclear translocation than CagA- H. pylori (Figure 2C). 
In line with this finding, the trancriptional activity of HIF-
1α was increased on infection with CagA+ H. pylori strains 
in accordance with H. pylori CagA expression status 
(Figure 2D). In addition, expression levels of the HIF-1α 
target genes Vegf-a, Pdk1, and Ldha were higher in CagA+ 
H. pylori, compared to CagA- H. pylori, without affecting 
Hif-1α mRNA levels (Figure 2E). These results suggest 
that infection with CagA+ H. pylori stimulates HIF-1α 
in gastric cells similar to that observed in the hypoxic 
response.
H. pylori CagA infection downregulates SIRT3 
activity in mitochondria via proteasomal 
degradation
To determine whether there were any changes in 
SIRT3 expression following infection with various H. pylori 
strains, we examined whole cell SIRT3 protein levels in H. 
pylori-infected cells. Total SIRT3 protein levels were not 
altered in H. pylori-infected cells (Figure 3A). We decided 
to measure SIRT3 protein levels and their enzymatic activity 
in the mitochondria by preparing mitochondrial extracts 
from H. pylori-infected cells. Interestingly, the protein 
levels and enzymatic activity of SIRT3 in mitochondria 
Figure 2: H. pylori CagA increases HIF-1α activity and induces expression of HIF-1α target genes. (A) AGS cells were 
infected with H. pylori strains for 6 h and the CagA protein level was analyzed by immunoblotting. (B) Lysates from AGS and MKN28 cells 
infected with H. pylori strains were immunoblotted with anti-HIF-1α, and then, the membrane was stripped and analyzed with anti-β-actin 
to standardize gel loading. (C) MKN28 cells were infected with H. pylori strains for 6 h, and then, cytoplasmic and nuclear fractions were 
separated. The nuclear proteins were analyzed by immunoblotting with anti-HIF-1α. To verify complete separation of the cytosolic and 
nuclear fractions, cytosolic and nuclear extracts were immunoblotted for aldolase A and lamin B. (D) MKN28 cells were co-transfected with 
HRE-Luc together with TK-renilla for 24 h and then infected with H. pylori strains for 12 h. Firefly luciferase activity was measured and 
normalized to Renilla luciferase activity. (E) MKN28 cells were infected with H. pylori for 12 h, and the fold change in HIF-1α target gene 
levels was measured by real-time PCR using specific primers for Vegf-a, Pdk-1, Ldha, and Hif-1α. Data are represented as mean ± SD (n = 3).
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were significantly reduced upon infection with CagA+ 
H. pylori, compared with CagA- H. pylori (Figure 3B 
and 3C). The low level of SIRT3 protein in mitochondria 
of CagA+ H. pylori-infected cells was intriguing. Some 
proteins involved in bioenergetic metabolism localized in 
the mitochondria (p53, p70, ODC, SOD1, etc.) are known 
to be degraded by an ubiquitin-independent process in 
response to oxidative stress [29, 30]. We investigated 
whether proteasomal degradation could contribute to the 
low level of mitochondrial SIRT3 protein in CagA+ H. 
pylori-infected cells. We pretreated cells with the specific 
proteasome inhibitor MG132 prior to H. pylori infection 
and found that MG132 was able to block SIRT3 protein 
degradation in cells (Figure 3D).
Increased ROS production induced by H. pylori 
CagA infection regulates HIF-1α stability
A fraction of expressed CagA protein has been 
reported to localize to mitochondria and produce significant 
amounts of ROS in infected cells. The mechanism 
by which CagA induces ROS production in gastric 
epithelial cells is not known [2, 31]. We thus examined 
whether H. pylori CagA protein localizes to mitochondria 
and increases ROS production. Immunoblotting after 
subcellular fractionation revealed CagA protein in both 
cytoplasmic and mitochondrial fractions (Figure 4A, left 
panel). In immunofluorescence analysis, with the CagA 
protein stained green and mitochondria stained red, yellow 
showed the colocalization of CagA and mitochondria 
in cells, consistent with the immunoblotting findings 
(Figure 4A, right panel). Next, we measured ROS levels 
using immunofluorescence assays and FACS analysis in 
AGS cells infected with the relevant H. pylori strains. 
Interestingly, we observed an increase of ROS in CagA+ 
H. pylori strains (Figure 4B), suggesting that CagA protein 
localized to the mitochondria has the potential to produce 
ROS. To determine whether the activation of HIF-1α 
is due to ROS, we treated AGS cells with antioxidants 
and determined the extent of HIF-1α activation. GSH 
precursor N-acetyl-cysteine (NAC), catalase, allopurinol, 
and DESF were added to cells before H. pylori infection. 
These antioxidants failed to downregulate HIF-1α 
expression (Figure 4C), implying that these antioxidants 
did not effectively scavenge the secreted extracellular 
oxidant in these cells. In order to determine the 
cellular source of ROS, DPI (complex I inhibitor) and 
myxothiazol (complex III inhibitor) were used to pretreat 
the cells before infection with H. pylori. Both inhibitors 
downregulated the stability and transcriptional activity 
of HIF-1α, indicating that the increased HIF-1α activity 
in CagA+ H. pylori-infected AGS cells was mainly due 
to ROS produced by mitochondrial complex I and III 
(Figure 4D).
Figure 3: H. pylori CagA downregulates SIRT3 activity in the mitochondria via proteasomal degradation. (A) SIRT3 
protein levels were detected by immunoblotting from AGS and MKN28 cells infected with H. pylori for 6 h. (B) Cytoplasmic (Cyt) and 
mitochondrial (Mito) proteins were fractionated from H. pylori-infected AGS and MKN28 cells after 6 h and analyzed by immunoblotting. 
Cox IV, a known mitochodrial protein, was detected as a control. (C) Relative activity of SIRT3 was measured using a fluorimetric 
method from the mitochondrial extracts of AGS and MKN28 cells infected with H. pylori for 6 h. Values represent fold changes relative 
to the control. (D) AGS or MKN28 cells were pretreated with MG132 (10 μM) for 1 h prior to infection with CagA+ H. pylori strains. 
The mitochondrial fraction was subjected to immunoblot analysis using anti-SIRT3 antibody. As a loding control, blots were stripped and 
reprobed with anti-Cox IV. Data are represented as mean ± SD (n = 3).
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CagA+ H. pylori-induced HIF-1α stabilization is 
regulated by post-translational modification
We next tested the hypothesis that CagA-induced 
HIF-1α stabilization may be due to post-translational 
modification, because there were no significant differences 
in HIF-1α mRNA levels in H. pylori-infected cells. We 
assessed HIF-1α stability by treating cells with MG-132 
to prevent hydroxylated HIF-1α from being degraded. 
Although CagA+ H. pylori infection stabilized more 
HIF-1α during MG-132 treatment, cells had significantly 
less hydroxylated HIF-1α, indicating that PHD activity 
was lower in CagA+ H. pylori-infected cells, compared 
to CagA- cells (Figure 5A). Of all the PHDs, PHD2 and 
PHD3 were detected in both gastric epithelial cell lines 
(Figure 5B), and PHD2 is known to be the primary 
mediator of hydroxylation [32]. Since CagA+ H. pylori 
infection influences HIF-1α stability through modulation 
of PHD activity, pretreatment with the potent PHD 
inhibitor DMOG in CagA- H. pylori-infected cells, as 
expected, showed relatively restored HIF-1α stabilization 
(Figure 5C). These results suggested that increased HIF-
1α expression contributes to reduced PHD activity in 
CagA+ H. pylori-infected cells (Figure 5D). CagA+ H. 
pylori activates HIF-1α through ROS-mediated alteration 
of PHD function, thereby altering hydroxylation and 
subsequent proteasomal degradation of HIF-1α.
SIRT3 gain of function inhibits HIF-1α activity 
and expression of HIF-1α target genes
We generated AGS and MKN28 cells stably 
expressing doxycycline-inducible SIRT3 and confirmed 
SIRT3 overexpression after the addition of doxycycline 
by immunoblotting (Figure 6A). By FACS analysis, 
SIRT3-overexpressing cells showed decreased ROS 
levels, compared to control cells, in the hypoxic 
condition (Figure 6B). When induced by doxycycline 
treatment, cells overexpressing SIRT3 clearly had 
both reduced HIF-1α protein stability and HIF-1α 
transcriptional activity under hypoxia, compared with 
the control (Figure 6C and 6D). Expression of the HIF-
1α responsive target genes Vegf-a, Pdk1, and Ldha was 
attenuated, corresponding to reduced HIF-1α activity, 
in SIRT3-overexpressing cells (Figure 6E). To examine 
whether SIRT3 has a role in inhibiting tumor growth 
in vivo, we injected SIRT3-overexpressing AGS cells 
into the flanks of nude mice. Tumor weights and volumes 
derived from SIRT3-overexpressing cells were smaller 
than those from the un-induced cells (Figure 6F).
Figure 4: H. pylori CagA protein localizes to mitochondria and is involved in ROS production. (A) Cytoplasmic (Cyt) 
and mitochondrial (Mito) proteins were fractionated from H. pylori-infected AGS cells and analyzed by immunoblotting (left panel) and 
immunofluorescence (right panel) with anti-CagA antibody. In immunofluorescence microscopy, CagA was stained in green, mitochondria 
in red, and DNA in blue with 4’,6-diamidino-2-phenylindole (magnification x100). (B) AGS cells were infected with H. pylori for 6 h 
and stained with Mitosox, followed by immunofluorescence (left panel) and FACS analysis (right panel). (C) AGS cells were pretreated 
with antioxidants (NAC, catalase, allopurinol, and DESF) prior to H. pylori infection and extracts were immunoblotted with HIF-1α 
antibody. (D) AGS cells were pretreated with DPI or myxothiazol and then the extracts were immunoblotted (left panel). AGS cell were 
co-transfected with HRE-Luc and TK-renilla constructs for 24 h and treated with the inhibitors DPI or myxothiazol for 1 h. Cells were then 
infected with CagA+ H. pylori strains for 6 h, and luciferase reporter activity was measured. Data are represented as mean ± SD (n = 3).
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CagA+ H. pylori infection showed increased HIF-1α 
stabilization and enhanced activity. We sought to determine 
the effect of SIRT3 overexpression on CagA+ H. pylori-
induced HIF-1α stabilization. We found that the level of 
HIF-1α protein was reduced in SIRT3-overexpressing cells 
infected with CagA+ H. pylori (Figure 6G). ROS levels, 
HIF-1α transcriptional activity, and expression of HIF-1α 
target genes were also downregulated in CagA+ H. pylori-
infected SIRT3-overexpressing cells (Figure 6H-6J), 
indicating that SIRT3 is an effector molecule responsible 
for negative regulation of ROS, HIF-1α, and tumor growth 
induced by H. pylori CagA. All of these findings suggest a 
novel mechanism whereby downregulation of SIRT3 in H. 
pylori CagA+ infected gastric cells induces ROS, HIF-1α 
activity, and tumor growth (Figure 7).
DISCUSSION
This study was designed to answer the question 
whether the tumor suppressor SIRT3 protein influences 
ROS production and HIF-1α activity in H. pylori-
infected gastric cancer cells. Using the established SIRT3 
knockdown or SIRT3 overexpressing gastric epithelial 
cells to investigate the role of SIRT3, we confirmed results 
from previous studies that suggested that SIRT3 functions 
as a tumor suppressor due to the suppression of ROS-
mediated HIF-1α activation [22].
Next, we examined the role of SIRT3 in regulating 
ROS/HIF-1α in H. pylori-infected gastric cells in vitro. 
In this study, H. pylori infection showed higher ROS 
production and HIF-1α activation in an oncoprotein 
CagA-dependent manner. The increased ROS triggered 
by CagA+ H. pylori might be attributed to the localization 
of CagA to the mitochondria (Figure 4A and 4B), 
with subsequent deregulation of the mitochondrial 
electron transport chain and production of superoxide 
[2, 31]. Vacuolating cytotoxin (VacA) protein, another 
known virulence factor of H. pylori, via pinocytosis 
and intracellular trafficking, induces vacuolation and 
epithelial cell apoptosis and this effect has been attributed 
Figure 5: CagA+ H. pylori-induced HIF-1α stabilization is regulated by prolyl hydroxylase (PHD) activity. (A) AGS cells 
were pretreated with or without 10 μM MG-132 for 1 h and infected with H. pylori for 6 h. Cell lysates were immunoblotted with antibodies 
specific for hydroxylated HIF-1α (OH-HIF-1α) and total HIF-1α. (B) After infection with H. pylori for 6 h, immunoblotting was performed 
using the indicated antibodies. (C) AGS cells were pretreated with or without 1mM DMOG for 2 h and infected with H. pylori for 6 h. 
Cell lysates were immunoblotted with anti-HIF-1α antibody. Densitometric ratios between HIF-1α and β-actin immunoblotting are shown 
at the bottom. (D) After treatment with the indicated inhibitors prior to CagA+ H. pylori infection, HIF-1α protein levels were detected by 
immunoblotting. Data are represented as mean ± SD (n = 3).
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to interactions with mitochondria [33–34]. It has been 
understood that VacA is capable of inducing an influx of 
Ca2+, resulting in the leakage of mitochondrial cytochrome 
c and the generation of reactive oxygen intermediates 
(ROI) [35–41]. We, however, observed that CagA induced 
significantly greater ROS production than VacA. This 
suggests that ROS-induced HIF-1 activation in H. pylori 
infected gastric cell lines is influenced by CagA protein 
more than VacA.
Interestingly, we found that antioxidants, such as 
NAC, catalase, allopurinol, etc., were unable to efficiently 
scavenge the secreted ROS in CagA+ H. pylori-infected 
gastric cells. Other reports have demonstrated that the 
amounts of catalase and superoxide dismutase (SOD) 
released by H. pylori are likely insufficient to clear excess 
extracellular oxidants [42] and that regulating the source 
of ROS generation is likely to be a more effective means 
of reducing ROS production. Therefore, we propose 
that impairment in the mitochondrial electron transport 
complex I or III by H. pylori CagA translocation results in 
increased ROS production and gives rise to a positive loop 
between ROS and HIF-1α.
It was previously reported that HIF-1α has a 
carcinogenic role in gastric cancer (43-44). Griffiths et al. 
investigated HIF-1α expression during carcinogenesis 
in H. pylori infection and showed that HIF-1α was not 
expressed in the normal gastric mucosa, while expression 
increased in density and intensity with sequential 
progression from H. pylori-infected mucosa to gastric 
cancer [43]. Another study observed increased VEGF 
expression, HIF-1α target gene expression, and new 
microvessel formation in H. pylori-infected gastric 
mucosa [44]. Here, we studied the possible linkage 
between oncogenic CagA protein and HIF-1α expression. 
In H. pylori-infected gastric epithelial cells, CagA+ H. 
pylori increased not only HIF-1α protein levels, but also 
HIF-1α activity and the expression of HIF-1α-target genes, 
including Vegf, Ldha, and Pdk1, even under normoxic 
Figure 6: SIRT3 gain of function inhibits HIF-1α activity and expression of HIF-1α target genes. (A) After generating 
derivatives of the gastric cancer cells AGS and MKN28 stably expressing doxycycline-inducible SIRT3, doxycycline (2 μM) was added to 
the cells for 48 h. Immunoblotting was then performed to detect SIRT3 overexpression using anti-Flag antibody. (B) Cells with inducible 
overexpression of SIRT3 were incubated in the presence or absence of Dox under normoxic (N, 21% O2) or hypoxic (H, 1% O2) conditions 
for 12 h, and then FACS analysis was performed to measure the amount of ROS. (C) For the immunoblotting assay, cells with inducible 
overexpression of SIRT3 in the presence or absence of Dox were incubated in normoxic or hypoxic conditions for 12 h. For the luciferase 
reporter assay (D) and for real time PCR (E) similar cells were incubated in normoxic or hypoxic conditions for 16 h. (F) Tumor volume 
and mass (left two panels) of SIRT3-overexpressing cells were measured. Pictures of tumors (third panel) are shown, and confirmation 
of SIRT3 overexpression by immunoblotting using lysates of the tumor samples (fourth panel). Each bar indicates the mean ± S.E. (n=4; 
*p<0.05). (G) After overexpressing SIRT3 in AGS cells with dox for 48 h, cells were infected with CagA+ H. pylori strains for 6 h. The 
HIF-1α protein level was detected by immunoblot analysis. (H) ROS levels were measured by FACS analysis. (I) HIF-1α transcriptional 
activity was measured by luciferase assay. (J) The expression levels of HIF-1α target genes (Vegf-1a, Pdk1, and Ldha) were measured by 
real-time PCR. Data are represented as mean ± SD (n = 3). * p< 0.05, ** p< 0.01, *** p< 0.001.
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conditions in vitro. We strongly believe that H. pylori 
oncogenic CagA induces ROS production to stabilize HIF-
1α and influences gastric cancer initiation and progression.
We also examined the relationship between SIRT3 
activity and ROS-induced HIF-1α activation in H. pylori 
infection. Surprisingly, we observed lower levels of SIRT3 
protein and activity in the mitochondria extracts of the 
CagA+ H. pylori infected cells. We attempted to identify 
a possible mechanism for the attenuation of SIRT3 in the 
mitochondria of CagA+ H. pylori-infected cells. Some 
studies have demonstrated that exposure of mammalian 
cells in culture to moderate oxidative stress significantly 
increases the degradation of intracellular proteins [45, 46]. 
The proteasome machinery appears to be upregulated in 
response to oxidative stress and to be responsible for the 
degradation of oxidized proteins in mammalian cells [45, 
47]. We confirmed that SIRT3 proteins are restored by 
blocking proteasomal activation, suggesting that oxidative 
stress by H. pylori infection can degrade SIRT3 protein. 
This is, however, still unclear, and additional study is 
required to understand how the H. pylori oncogenic CagA 
induces the degradation of mitochondrial SIRT3. We also 
Figure 7: Proposed model depicting the regulation of HIF-1α by downregulated SIRT3-mediated ROS production in 
H. pylori-infected gastric cells. Infection with H. pylori CagA+ induces SIRT3 protein degradation by proteasome activity. Increased 
ROS generation from the downregulated SIRT3 activity mediates the activation of HIF-1α, and this, in turn, induces the expression of HIF-
1α target genes, which leads to gastric cancer proliferation.
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confirmed that the gain of function of SIRT3 can recover 
the metabolic change in H. pylori infected gastric cancer 
cells. We found that HIF-1α activity, ROS production, and 
HIF-1α target gene expression were relatively decreased 
in SIRT3 overexpressing cells with CagA+ H. pylori 
infection.
In conclusion, this study suggests that H. pylori-
mediated gastric carcinogenesis could be attributed to 
hypoxic activation of HIF-1α activity via downregulation 
of mitochondrial SIRT3 in CagA+ H. pylori-infected 
gastric cancer. SIRT3 may be a valuable effector molecule 
for gastric cancer prevention, as well as a potential 
treatment strategy.
MATERIALS AND METHODS
Bacteria, cell culture, and infection with H. pylori
The H. pylori strains used were 60190 (cagPAI+, 
ATCC 49503), 8822 (cagPAI-), ΔcagA (an isogenic mutant 
of 60190 lacking cagA), and ΔvacA (an isogenic mutant 
of 60190 lacking vacA). H. pylori strains were cultured 
on agar plates containing 10% horse serum at 37°C in 
a microaerobic atmosphere, using the Campy Container 
System (BBL). Human gastric epithelial cells (AGS and 
MKN28) were cultured in RPMI-1640 medium (Gibco) 
supplemented with 10% fetal bovine serum (FBS) and 
1% penicillin-streptomycin sulfate. All cultures were 
maintained in a 37°C incubator supplemented with 5% 
CO2. Gastric epithelial cells were seeded in tissue culture 
plates at 48 h before infection and allowed to grow to 
approximately 80% confluence. At 2 h prior to infection, 
the medium was replaced by fresh medium containing 
0.5 % FBS. For infection, bacteria were harvested in 
phosphate-buffered saline (PBS) (pH 7.4) and added to 
the host cells at multiplicities of infection (MOIs) of 100 
for varying times. Hypoxic conditions were generated 
by placing cells in a sealed hypoxic incubator (Thermo 
Scientific, MA, USA). The O2 level in this chamber was 
maintained at 1%, with the residual gas mixture containing 
5% CO2 and 94% N2.
Antibodies and chemicals
Anti-HIF-1α, anti-CagA, anti-PHD1, anti-
PHD3, anti-Aldolase A, anti-Lamin B, and anti-β-actin 
were purchased from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA, USA). An anti-HIF-1α antibody was 
also purchased from BD Biosciences (San Jose, CA, 
USA). Anti-SIRT3, anti-PHD2, anti-Cox IV, and anti-
hydroxylated-HIF-1α were purchased from Cell Signaling 
Biotechnology (Danvers, MA, USA). The antioxidant 
inhibitors and chemicals were purchased from Sigma (St 
Louis, MO, USA).
Immunoblotting
Whole cell extracts were prepared with RIPA 
buffer containing 50 mM Tris (pH 7.5), 1 mM EDTA, 
150 mM NaCl, 0.1% SDS, 0.1% NaDeOC, 1% NP-40, 
and complete protease inhibitor (Roche Applied Science). 
Lysates were separated by SDS-PAGE and transferred to 
polyvinylidene difluoride membranes (Millipore, Billerica, 
MA, USA). Membranes were incubated with appropriate 
primary antibodies overnight at 4°C. Immunodetection 
was performed using an enhanced chemiluminescence 
reagent (Thermo Fisher Scientific), according to the 
manufacturer’s instructions.
Plasmids
pcDAN3.1-SIRT3 Flag vector (No. 13814) was 
obtained from Addgene (Cambridge, MA, USA). To 
generate a lentiviral transfer vector with Flag-tagged 
SIRT3, pcDAN3.1-SIRT3 Flag vector was digested with 
restriction enzymes BamHI and XbaI and ligated into 
enzyme-digested pLVX-tight puro vector (Clontech, CA, 
USA). SIRT3 pLKO.1 shRNA vectors were purchased 
from Sigma (TRCN0000038892), and the control pLKO.1 
scrambled vector was obtained from Addgene.
Luciferase activity assay
HRE-luc plasmid (graciously provided by Prof. 
L. Guarente) was used to measure HIF-mediated 
transcriptional activity. Cells (3×105) were plated into each 
well of a six-well plate and were transfected the next day 
using LipofectAMINE 2000 (Invitrogen) with 1 μg of HRE-
luciferase plasmid, containing three copies of HRE from the 
pgk-1 gene, and 0.05 μg of pRL-TK plasmid. At 24 h after 
transfection, cells were infected with H. pylori or incubated 
in a hypoxia chamber. Subsequently, cells were lysed, and 
luciferase activities were measured using a dual-luciferase 
reporter assay kit (Promega, Madison, WI, USA) according 
to the manufacturer’s protocol. Luciferase activity was 
measured using a luminometer (Berthold Technologies, 
Bad Wildbad, Germany). Values for firefly luciferase were 
normalized to Renilla (pRL-TK) vector and presented as 
fold induction, compared to control.
Real-time PCR
Total RNA was isolated using TRIzol Reagent 
(Invitrogen) according to the manufacturer’s instructions. 
Complementary DNA was produced with SuperScript II 
reverse transcriptase (Invitrogen, Carlsbad, CA, USA) at 
42°C for 1 h. The mixture was then boiled for 5 min to 
inactive reverse transcriptase and quickly chilled on ice. 
Synthesized cDNAs were analyzed by real-time PCR 
using SYBR Green master mix (Applied Biosystems, 
Foster City, CA, USA) and the ABI PRISM 7000 
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Quantitative PCR system (Applied Biosystems). Each 
reaction was performed in triplicate, and the amounts of 
the PCR products produced were normalized with respect 
to β-actin.
Subcellular fractionation
Cytosolic and nuclear protein extraction: H. pylori-
infected AGS cells were harvested and separated into 
cytoplasmic and nuclear fractions using CEB buffer 
(10 mM Tris-HCl, pH 8, 60 mM KCl, 1 mM EDTA, 
1 mM dithiothreitol), containing 0.5% Nonidet P-40 and 
protease inhibitors. The cytoplasmic fraction was clarified 
by centrifugation at 1200 × g for 5 min, and the nuclear 
pellet was washed with CEB buffer to remove cytoplasmic 
contamination. The nuclear pellet was lysed with NEB 
buffer (20 mM Tris-HCl, pH 8, 0.4 M NaCl, 1.5 mM 
MgCl2, 1.5 mM EDTA, 1 mM dithiothreitol) containing 
0.5% Nonidet P-40 and protease inhibitors. Nuclear 
proteins were analyzed by immunoblotting as described 
above.
Mitochondrial protein extraction: Mitochondrial and 
cytosolic fractions were extracted using a mitochondria 
isolation kit (Pierce Biotechnology, Inc., Rockford, 
IL, USA) following the manufacturer’s protocol. The 
cytoplasmic fraction was concentrated by acetone 
precipitation, and isolated mitochondria were lysed 
with RIPA buffer. Then equal amounts of protein were 
subjected to direct immunoblot analysis.
ROS determination
Superoxide production was determined by measuring 
MitoSOX or DHE (dihydroethidium, Invitrogen) oxidation 
in cells, following the manufacturer’s instructions. Cells 
were cultured as described above, and the cells were 
washed once with PBS and incubated for 20 min at 37°C 
in RPMI-1640 containing 5 μM MitoSOX or 20 μM DHE 
before being trypsinized, resuspended, and measured 
by flow cytometry. For confocal immunofluorescence 
microscopy, H. pylori-infected cells were stained with 
MitoSOX (5 μM) for 20 min at 37°C, washed with 
PBS, and counterstained with mounting medium for 
fluorescence. Slides were sealed with coverslips and 
examined for immunofluorescence using a confocal laser-
scanning microscope (LSM 700; Carl Zeiss, Thornwood, 
NY, USA).
Immunofluorescence microscopy
H. pylori-infectedAGS cells were stained with 
Mitotracker for 30 min at 37°C, fixed in ice-cold methanol 
for 10 min, and washed with PBS. Nonspecific binding 
was blocked with 3% bovine serum albumin (BSA) in 
PBS for 30 min, followed by incubation with anti-CagA 
rabbit polyclonal antibody in 2% BSA in PBS at 4°C 
overnight. After washing with PBS, CagA was visualized 
by treatment with fluorescein isothiocyanate-conjugated 
goat anti-rabbit polyclonal secondary antibody for 60 
min at room temperature. Cells were washed with PBS, 
mounting medium for fluorescence was added, and the 
slides were sealed with coverslips before examination 
for immunofluorescence using a confocal laser-scanning 
microscope.
SIRT3 enzymatic activity assay
SIRT3 enzymatic activity was assayed with the 
Fluorogenic SIRT3 assay kit (BPS Bioscience, CA, USA) 
following the manufacturer’s instructions, with slight 
modifications. Mitochondrial protein (1 μg) was incubated 
at 37°C for 45 min with specific substrates; 25 μl of 
developer was added; and after 45 min of incubation, 
SIRT3 activity was measured using a fluorimetric 
microplate reader at 360 nm/460 nm.
Immunohistochemical staining
To quantify angiogenesis, microvessel density 
was determined by counting CD31-positive vessels. 
Tissues from nude mice were fixed overnight in formalin 
at 4°C and embedded in paraffin. Tissue sections were 
deparaffinized with xylene, hydrated in serial dilutions 
of alcohol, and immersed in 3% H2O2. Following antigen 
retrieval by heat mediation in a Tris/EDTA buffer (pH 9) 
solution, the tissue sections were incubated with protein-
blocking agent (Immunotech, Marseille, France) to 
block nonspecific antibody binding for 30 min at room 
temperature and then incubated overnight at 4°C with 
primary antibody against anti-CD31 (Abcam, 1:200) in a 
humidified chamber. After washing with PBS three times, 
the sections were incubated with a biotinylated secondary 
antibody and streptavidin conjugated to horseradish 
peroxidase (Immunotech) for 60 min at room temperature, 
followed by a PBS wash. The chromogen was developed 
for various times with liquid 3,3’-diaminobenzidine 
(Immunotech) followed by counterstaining with Meyer’s 
hematoxylin. Slides were examined under a light 
microscope.
Xenografts
First, 5 × 106 AGS cells were resuspended in 100 μl 
of serum-free RPMI-1640 medium with Matrigel and then 
injected subcutaneously into either flank of six-week-old 
BALB/c nude mice (OrientBio, Kapyoung, Korea). For the 
doxycycline-treated tumor group, AGS cells expressing 
SIRT3 were first treated with doxycycline (2 μg/ml) for 
2 days to induce SIRT3 expression. 5 × 106 of these cells 
in 100 μl serum-free RPMI-1640 medium with Matrigel 
were injected into the nude mice. After injection, mice 
were given doxycycline (1 mg/ml) with drinking water 
for three months. The bottles of water were changed 
weekly. The tumors were measured weekly by calipers, 
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and their volumes were calculated as V = L × W2 × 0.5 
(length L and width W). At the end of the experiment, 
mice were sacrificed and tumors were weighed. Tissues 
were removed for RT-PCR, immunoblotting, and IHC.
Statistical analysis
Statistical analyses were performed using SPSS 18.0 
software. All values are expressed as the mean ± standard 
deviation. Comparisons between two groups were 
analyzed using t-tests, and one-way ANOVA with a post 
hoc Bonferroni test was used for multiple comparisons. 
P-values <0.05 were considered statistically significant.
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